Latest Period
Q2 2026
Security Snapshot
PHIBRO ANIMAL HEALTH CORP - CLASS A COMMON STOCK (PAHC) Institutional Ownership
CUSIP: 71742Q106
13F Institutional Holders and Ownership History from Q2 2014 to Q2 2026
Institutions Reporting
206
Shares (Excl. Options)
20,989,091
Price
$31.40
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / CLASS A COMMON STOCK
- Symbol
- PAHC on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 20,989,091
- Total 13F value
- $659,150,178
- Portfolio coverage rank
- 0%
- Share change
- +719,656
- Value change
- -$16,684,560
- Number of holders
- 206
- Shares outstanding
- 21,068,539
- SEC-reported price per share
- $33.86
- Insider filing price
- $33.86
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- PAHC - PHIBRO ANIMAL HEALTH CORP - CLASS A COMMON STOCK is tracked under CUSIP 71742Q106.
- 206 institutions reported positions in Q2 2026.
- 8 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 256 to 206 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,124,255,744 to $659,150,178.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 206 institutions filings for Q2 2026.
Security key
71742Q106
Latest holder period
Q2 2026
13F holders
206
13D/G owners
8
CIK / CUSIP context first
Open Q2 2026 holders
PAHC full holder history
PHIBRO ANIMAL HEALTH CORP SEC filings
PHIBRO ANIMAL HEALTH CORP company facts
PHIBRO ANIMAL HEALTH CORP insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 71742Q106:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
8
Security
PAHC
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BFI Co., LLC | 48% | -2.2% | $1,081,431,408 | -$24,781,535 | 19,552,186 | -2.2% | BFI Co., LLC | 20 May 2026 |
| BlackRock, Inc. | 16% | $57,576,134 | 3,195,124 | BlackRock, Inc. | 31 Mar 2025 | |||
| FMR LLC | 15% | $104,289,270 | 3,160,281 | FMR LLC | 30 Jun 2026 | |||
| MILLENNIUM MANAGEMENT LLC | 5.1% | $33,428,691 | 1,064,608 | Millennium Management LLC | 23 Jul 2026 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5.1% | $57,733,795 | 1,043,822 | Vanguard Capital Management | 31 Mar 2026 | |||
| PZENA INVESTMENT MANAGEMENT LLC | 3.6% | -51% | $13,043,417 | -$13,280,199 | 723,830 | -50% | PZENA INVESTMENT MANAGEMENT LLC | 31 Mar 2025 |
| BRANDES INVESTMENT PARTNERS, LP | 3.3% | $11,942,719 | 662,748 | Brandes Investment Partners, L.P. | 31 Dec 2024 | |||
| BARCLAYS PLC | 1.3% | -77% | $14,584,970 | -$43,097,165 | 263,695 | -75% | Barclays PLC | 31 Mar 2026 |
As of 30 Jun 2026, 206 institutional investors reported holding 20,989,091 shares of PHIBRO ANIMAL HEALTH CORP - CLASS A COMMON STOCK (PAHC). This represents 100% of the company’s total 21,068,539 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
78%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 15% | 3,219,040 | -1.1% | 0% | $101,077,857 |
| FMR LLC | 15% | 3,160,281 | +45% | 0% | $99,232,821 |
| STATE STREET CORP | 4.9% | 1,038,382 | +9.3% | 0% | $32,605,195 |
| MILLENNIUM MANAGEMENT LLC | 4.4% | 936,701 | +1578% | 0.02% | $29,412,411 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4% | 923,318 | +3.6% | 0% | $28,992,185 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.1% | 657,350 | +8.7% | 0% | $20,644,155 |
| LORD, ABBETT & CO. LLC | 3.1% | 653,305 | +64% | 0.06% | $20,514,000 |
| DIMENSIONAL FUND ADVISORS LP | 2.5% | 531,087 | +4.6% | 0% | $16,677,205 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.4% | 508,486 | +3.7% | 0% | $15,966,460 |
| RENAISSANCE TECHNOLOGIES LLC | 2.3% | 480,500 | -17% | 0.02% | $15,087,700 |
| CastleKnight Management LP | 2.2% | 461,322 | +508% | 0.53% | $14,485,511 |
| MORGAN STANLEY | 2% | 412,634 | +5.5% | 0% | $12,956,744 |
| Dana Investment Advisors, Inc. | 1.8% | 387,867 | +35% | 0.32% | $12,179,024 |
| Invesco Ltd. | 1.6% | 336,329 | +1.6% | 0% | $10,560,731 |
| Nuveen, LLC | 1.5% | 314,079 | -31% | 0% | $9,862,080 |
| OBERWEIS ASSET MANAGEMENT INC/ | 1.5% | 311,100 | +12% | 0.2% | $9,768,540 |
| Ranger Investment Management, L.P. | 1.4% | 292,410 | +5% | 0.58% | $9,181,674 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.2% | 260,861 | -1.3% | 0% | $8,191,035 |
| Bank of New York Mellon Corp | 1.2% | 254,380 | +11% | 0% | $7,987,543 |
| Allspring Global Investments Holdings, LLC | 1.2% | 254,234 | -11% | 0.01% | $7,982,948 |
| NORTHERN TRUST CORP | 1.1% | 237,528 | +8.3% | 0% | $7,458,378 |
| ACADIAN ASSET MANAGEMENT LLC | 1.1% | 226,935 | -63% | 0.01% | $7,120,000 |
| HENNESSY ADVISORS INC | 1.1% | 221,700 | 0.22% | $6,961,380 | |
| CRAWFORD INVESTMENT COUNSEL INC | 0.97% | 205,256 | +9.5% | 0.11% | $6,445,038 |
| GLOBEFLEX CAPITAL L P | 0.9% | 189,224 | -9.9% | 0.76% | $5,941,665 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
49
Latest
Q2 2026
Rows shown
1-25 of 49
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 20,989,091 | $659,150,178 | -$16,684,560 | $31.40 | 206 |
| 2026 Q1 | 20,359,567 | $1,124,255,744 | +$63,676,784 | $55.31 | 256 |
| 2025 Q4 | 19,327,676 | $722,326,211 | -$11,276,690 | $37.36 | 227 |
| 2025 Q3 | 19,599,542 | $792,990,493 | -$23,250,468 | $40.46 | 216 |
| 2025 Q2 | 20,349,724 | $519,721,694 | +$4,932,349 | $25.54 | 192 |
| 2025 Q1 | 20,230,331 | $431,882,531 | -$6,976,163 | $21.36 | 181 |
| 2024 Q4 | 20,760,076 | $435,958,146 | +$5,855,068 | $21.00 | 171 |
| 2024 Q3 | 20,262,212 | $456,562,597 | +$4,978,935 | $22.52 | 145 |
| 2024 Q2 | 20,104,261 | $337,332,099 | -$3,613,178 | $16.77 | 138 |
| 2024 Q1 | 20,390,841 | $263,815,154 | +$4,780,079 | $12.93 | 137 |
| 2023 Q4 | 20,498,053 | $237,357,830 | +$2,393,108 | $11.58 | 134 |
| 2023 Q3 | 20,056,787 | $257,066,743 | +$637,840 | $12.77 | 124 |
| 2023 Q2 | 19,973,690 | $273,662,577 | -$4,846,655 | $13.70 | 127 |
| 2023 Q1 | 20,301,393 | $311,012,290 | +$5,422,420 | $15.32 | 132 |
| 2022 Q4 | 19,989,777 | $268,089,718 | +$1,271,732 | $13.41 | 129 |
| 2022 Q3 | 19,929,636 | $264,908,464 | -$16,816,591 | $13.29 | 138 |
| 2022 Q2 | 20,667,086 | $395,381,581 | +$3,633,408 | $19.13 | 139 |
| 2022 Q1 | 20,531,472 | $408,823,760 | +$4,262,047 | $19.95 | 143 |
| 2021 Q4 | 20,288,359 | $413,858,025 | -$6,010,185 | $20.42 | 133 |
| 2021 Q3 | 20,413,494 | $439,740,209 | -$19,573,080 | $21.54 | 130 |
| 2021 Q2 | 21,302,215 | $615,117,148 | +$14,536,483 | $28.88 | 142 |
| 2021 Q1 | 21,042,222 | $513,508,005 | +$22,206,837 | $24.40 | 137 |
| 2020 Q4 | 20,306,618 | $394,390,866 | -$4,768,468 | $19.42 | 129 |
| 2020 Q3 | 20,646,036 | $359,251,334 | -$10,719,506 | $17.40 | 131 |
| 2020 Q2 | 44,667,289 | $1,140,259,090 | +$598,684,081 | $26.27 | 148 |